The ACME Laboratories Ltd. (DSE:ACMELAB)

Heartland Financial USA Revenue

The ACME Laboratories had revenue of 9.25B BDT in the quarter ending March 31, 2025, with 15.58% growth. This brings the company's revenue in the last twelve months to 34.75B, up 12.77% year-over-year. In the fiscal year ending June 30, 2024, The ACME Laboratories had annual revenue of 31.93B with 18.49% growth.

• Revenue (ttm): 34.75B
• Revenue Growth: +12.77%
• P/S Ratio: 0.49
• Revenue / Employee: 3.74M
• Employees: 9,301
• Market Cap: 17.01B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	31.93B	4.98B	18.49%
Jun 30, 2023	26.95B	3.09B	12.95%
Jun 30, 2022	23.86B	3.09B	14.87%
Jun 30, 2021	20.77B	1.77B	9.30%
Jun 30, 2020	19.00B	2.70B	16.53%